BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1663439)

  • 1. Succimer, an oral lead chelator.
    Mann KV; Travers JD
    Clin Pharm; 1991 Dec; 10(12):914-22. PubMed ID: 1663439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
    Miller AL
    Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succimer: the first approved oral lead chelator.
    Jorgensen FM
    Am Fam Physician; 1993 Dec; 48(8):1496-502. PubMed ID: 8249780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelation therapy to treat lead toxicity in children.
    Wegmann K
    Minn Med; 1992 Nov; 75(11):25-7. PubMed ID: 1331737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
    Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
    N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.
    Lasky RE; Laughlin NK; Luck ML
    Environ Res; 2001 Sep; 87(1):21-30. PubMed ID: 11534961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of succimer on the absorption of lead in adults determined by using the stable isotope 204Pb.
    Smith DR; Markowitz ME; Crick J; Rosen JF; Flegal AR
    Environ Res; 1994 Oct; 67(1):39-53. PubMed ID: 7925193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
    Glotzer DE
    Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.